Aaron Kantoff
Director, Centessa Pharmaceuticals plc.
Companies
- Avalo Therapeutics, Inc.Board member Apr 3, 2024 to now1
- Tourmaline Bio, Inc.Board member Oct 23, 2023 to now2
- Centessa Pharmaceuticals plcBoard member May 27, 2021 to Nov 18, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Avalo Therapeutics, Inc. AVTX6,333 shares4$73.3K at $11.58Mar 28, 2026
- Tourmaline Bio, Inc.0 shares5Oct 28, 2025
- Centessa Pharmaceuticals plc60,000 shares6Nov 18, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 28, 2026Exercised options 3,166 shares of Avalo Therapeutics, Inc.4
- Oct 28, 2025U 88,281 shares of Tourmaline Bio, Inc.5
- Oct 24, 2025Gift 5,000 shares of Tourmaline Bio, Inc.7
- Sep 5, 2025Exercised options 10,000 shares at $9.46 of Tourmaline Bio, Inc.8
- Sep 5, 2025Exercised options 37,890 shares at $0.13 of Tourmaline Bio, Inc.8
- Mar 28, 2025Exercised options 3,167 shares of Avalo Therapeutics, Inc.9
- Oct 24, 2023Bought 7,500 shares at $11.86 of Tourmaline Bio, Inc.10
- Oct 19, 2023Granted 37,891 shares of Tourmaline Bio, Inc.11
- Nov 18, 2021Bought 10,000 shares at $11.99 of Centessa Pharmaceuticals plc6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARTourmaline Bio, Inc., Board member
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Oct 24, 2025
- 8SEC EDGARForm 4 filed Sep 9, 2025
- 9SEC EDGARForm 4 filed Apr 1, 2025
- 10SEC EDGARForm 4 filed Oct 26, 2023
- 11SEC EDGARForm 4 filed Oct 23, 2023